News New breakthrough designations for Roche's Alecensa and Actem... Alecensa and Roactemra are breakthroughs, says FDA.
News FDA launches genome sequencing app competition Winning apps will aid in the wider Precision Medicine Initiative.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News FDA launches app competition to take on opioid abuse 2016 Naloxone App Competition seeks app to connect opioid users with naloxone carriers.
News FDA's Duchenne drug approval greeted with joy, but remains c... FDA will require efficacy evidence.
Views & Analysis Meeting pharmacovigilance standards in the US and Europe Examining statistics on recent inspections gives insight into the issues commonly faced.
News Wnt drug gives MSD first eye disease win after EyeBio deal MSD's return to the ophthalmology field has been charged up with a positive phase 3 trial of Wnt-targeted remigromig in diabetic macular oedema.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
